DrugPatentWatch Database Preview
Watson Pharms Teva Company Profile
What is the competitive landscape for WATSON PHARMS TEVA, and what generic and branded alternatives to WATSON PHARMS TEVA drugs are available?
WATSON PHARMS TEVA has nine approved drugs.
Summary for Watson Pharms Teva
| US Patents: | 0 |
| Tradenames: | 6 |
| Ingredients: | 5 |
| NDAs: | 9 |
Drugs and US Patents for Watson Pharms Teva
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Pharms Teva | NORETHIN 1/35E-21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 071480-001 | Apr 12, 1988 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Pharms Teva | ATRACURIUM BESYLATE | atracurium besylate | INJECTABLE;INJECTION | 074945-001 | Jul 28, 1998 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Pharms Teva | AMOXAPINE | amoxapine | TABLET;ORAL | 072419-001 | May 11, 1989 | DISCN | No | No | Start Trial | Start Trial | |||||
| Watson Pharms Teva | ZOVIA 1/35E-21 | ethinyl estradiol; ethynodiol diacetate | TABLET;ORAL-21 | 072720-001 | Dec 30, 1991 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
